Kimia Biosciences (KIMIABL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
No financial overview data available.
Kimia Biosciences Income Statement
No income statement data available.
Kimia Biosciences Balance Sheet
No balance sheet data available.
Kimia Biosciences Cash Flow Statement
No cash flow data available.
Kimia Biosciences Key Financial Ratios
Valuation Ratios
Price to Book
25.64
Price to Sales
2.15
Profitability Ratios
Profit Margin
8.08%
Operating Margin
19.09%
Return on Equity
186.70%
Return on Assets
9.99%
Financial Health
Current Ratio
0.92
Debt to Equity
394.92
Beta
1.14
Per Share Data
Book Value per Share
₹2.11
Revenue per Share
₹25.14
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| kimiabl | 2.6B | - | 25.64 | 186.70% | 8.08% | 394.92 |
| Sun Pharmaceutical | 3.9T | 37.37 | 5.42 | 15.08% | 19.29% | 3.26 |
| Divi's Laboratories | 1.6T | 70.40 | 10.87 | 14.64% | 23.89% | 0.03 |
| Sun Pharma Advanced | 48.2B | -13.32 | - | 157.88% | -45.53% | -1.24 |
| Aarti Drugs | 44.8B | 23.77 | 3.28 | 12.28% | 7.80% | 44.92 |
| Sequent Scientific | 44.8B | 210.48 | 6.35 | 4.35% | 1.41% | 62.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.